Evidence map›Paper›PMID 36187297›Full record

ArticleFrontiers in cellular neuroscience2022

A novel automated morphological analysis of Iba1+ microglia using a deep learning assisted model.

Lucas Stetzik, Gabriela Mercado, Lindsey Smith, Sonia George, Emmanuel Quansah, Katarzyna Luda, Emily Schulz, Lindsay Meyerdirk, Allison Lindquist, Alexis Bergsma and 5 more

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lucas StetzikParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Gabriela MercadoParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Lindsey SmithAiforia Inc, Cambridge Innovation Center, Cambridge, MA, United States.
Sonia GeorgeParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Emmanuel QuansahParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Katarzyna LudaDepartment of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, United States.
Emily SchulzParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Lindsay MeyerdirkParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Allison LindquistParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Alexis BergsmaDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, United States.
Russell G JonesDepartment of Metabolism and Nutritional Programming, Van Andel Institute, Grand Rapids, MI, United States.
Lena BrundinParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Michael X HendersonParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
John Andrew PospisilikDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, United States.
Patrik BrundinParkinson's Disease Center, Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.

Funding

Linking Synucleinopathy and Dysfunction of Olfactory PathwaysR01DC016519 · NIDCD · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN, WESSON, DANIEL W · 2017 to 2021
$2.8M
Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons diseaseR21NS106078 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI BRUNDIN, PATRIK, KORDOWER, JEFFREY H · 2019 to 2020
$921k
Role of T cells in alpha-synuclein pathologyR21NS122376 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN · 2021 to 2021
$525k
NIDCD NIH HHS R01 DC016519NINDS NIH HHS R21 NS106078NINDS NIH HHS R21 NS122376
6 · The paper itself

Abstract

There is growing evidence for the key role of microglial functional state in brain pathophysiology. Consequently, there is a need for efficient automated methods to measure the morphological changes distinctive of microglia functional states in research settings. Currently, many commonly used automated methods can be subject to sample representation bias, time consuming imaging, specific hardware requirements and difficulty in maintaining an accurate comparison across research environments. To overcome these issues, we use commercially available deep learning tools Aiforia

Indexed as

deep learningmicrogliaolfactory dysfunctionParkinson’s diseasesynucleinviral infection

Identifiers

PMID36187297
PMCPMC9520629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.